Abstract
AbstractPeyronie’s Disease (PD) causes penile curvature and pain in acute phase. In two preclinical studies, tamoxifen and vardenafil (T&T) together showed to be effective in the acute phase. The aim of this study was to describe the clinical results of the off-label treatment of PD patients with T&T in combination with vacuum erection device (VED) in St Antonius hospital, urology outpatient clinic. Baseline descriptive Statistics, Fisher Exact and Chi-Square Test were used. 48 Men were included, mean age 53.0 years (SD 9.5), baseline curvature 46.7° (SD 18.8), median duration four months, 70.8% (n = 48) painful erections. Dorsal curvature is found in 27 (56.3%) men, mean stretched penile length 13.4 cm. Mean use of T&T was 13 weeks (1–52 weeks). Curvature improvement in 27.7% men, pain reduction in 48.5% men, sexual intercourse/coitus improvement in 34.2% men, erection improvement in 14.6% men. Adverse reactions of T&T in 39.6% (n = 19). This was the first study investigating the use of T&T in acute phase PD patients. 27.7% of patients reported improvement in curvature with T&T.
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Mohede DCJ, van Driel MF, de Jong IJ, et al. Peyronie’s disease—current perspectives. Tijdschr Urol. 2018;8:112–20.
2. Salonia A, Bettoocchi C, Carvalho J, et al. Guidelines on sexual and reproductive health. EAU; 2020. pp. 10–31.
3. Patel D, Christensen M, Hotaling J, et al. A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie’s disease. World J Urol. 2020;38:253–61.
4. Ostrowski KA, Gannon JR, Walsh TJ. A review of the epidemiology and treatment of peyronie’s disease. Res Reports. Urol. 2016;8:61–70.
5. Kadioglu A, Tefekli A, Erol B, et al. A retrospective review of 307 men with peyronie’s disease. J Urol. 2002;168:1075–9.